Steven Cohen’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding CBIO
OM
Steven Cohen's CBIO Position: Q3 2026 in Review
Steven Cohen sold out of Crescent Biopharma (CBIO) in Q3 2026, closing a stake of 300,000 shares — an estimated $5.4M sold.
Steven Cohen first reported a position in CBIO in Q2 2017 and held it in 7 quarters. The position peaked at $5.51M in Q1 2026. 106 funds tracked by Wall St. Rank hold CBIO as of Q3 2026.
- Steven Cohen reported no remaining Crescent Biopharma position as of Q3 2026 after selling out during the quarter.
- Steven Cohen sold 300,000 Crescent Biopharma shares in Q3 2026, an estimated $5.4M.
- Steven Cohen first reported a position in Crescent Biopharma in Q2 2017 and held it in 7 quarters.
- Steven Cohen's Crescent Biopharma position peaked at $5.51M in Q1 2026.
- 106 funds tracked by Wall St. Rank held Crescent Biopharma as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.